- This event has passed.
Virtual Fundraiser – The Way of the Psychonaut: Stanislav Grof’s Journey of Consciousness.
Thursday December 3 @ 7:30 pm - 9:30 pm
Don’t miss out – the FIRST Australian VIRTUAL SCREENING of The Way of the Psychonaut.
Our previous film screenings have sold out within a few days of being announced. Get your ticket early if you missed out!
“In the kind of world we have today, transformation of humanity will be our only real hope for survival.” – Dr Stanislav Grof
Mind Medicine Australia is thrilled to invite you to join us for an exclusive screening of The Way of the Psychonaut: Stanislav Grof’s Journey of Consciousness. This inspirational documentary is being shown in Australia to a global audience after four years in the making, and we are excited to share it with you! The Way of the Psychonaut showcases Stan Grof’s groundbreaking work in human consciousness with psychedelics, Holotropic Breathwork and Transpersonal Psychology.
Stan’s quest for knowledge and insights into the healing power of non-ordinary states of consciousness, influenced the disciplines of psychiatry and psychology and profoundly changed many individual lives. One of those transformed by Stan is filmmaker Susan Hess Logeais. The documentary utilises Susan’s personal existential crisis as a gateway to examine Grof’s impact, from the micro to the macro.
“Psychedelics, used responsibly and with proper caution, would be for psychiatry what the microscope is for biology and medicine or the telescope is for astronomy.” – Dr Stanislav Grof
Date: Thursday 3rd December 2020
Time: 7:30pm sharp – 9:30pm (includes Q&A Panel)
Location: Online (a link will be included in your Humanitix ticket)
Ticket Price: $20 Concession / $35 General Admission / $50 General Admission + Donation (includes $15 donation) / $100 General Admission + Donation (includes $65 donation)
(All funds donated will go towards our mission to make these medicines available and accessible.)
You can watch the preview here:
Following the screening there will be a Q & A panel with a special guest appearance from Dr Stan and Brigitte Grof (USA) and Susan Hess Logeais (USA), the film’s producer. This will be an incredible opportunity to engage with one of the pioneers of psychedelic-assisted therapy and learn from the filmmaker and what inspired her to pursue this project.
Director/Editor: Susan Hess Logeais
Producers: Susan Hess Logeais, Stan Grof and Brigitte Grof
More about medicinal MDMA
Psychedelic-assisted treatments offer enormous potential in providing a meaningful alternative to current treatments for mental illness. PTSD is a debilitating condition that affects tens of millions of people worldwide, with many more trauma victims diagnosed with comorbid conditions such as depression, anxiety and eating disorders. In recent clinical trials, MDMA has been shown to produce reliable clinical improvements, restoring patient safety and self-agency even for individuals who have suffered with PTSD for many years, and for whom many treatments have failed.
Results from Phase 2 clinical trials over the past decade have been so compelling that the Food and Drug Administration (FDA) in the United States recently designated MDMA-assisted psychotherapy as a ‘Breakthrough Therapy’. This designation highlights the FDA’s anticipation that these therapies may offer substantial advantage over current treatments. If forthcoming Phase 3 results confirm these treatments are effective, MDMA-assisted treatment of PTSD may become a prescription medicine as early as 2021 in some jurisdictions.
The wave of clinical psychedelic research and regulatory support is rapidly building, with experts forecasting the availability of psychedelic-assisted treatments in the US and EU within the next 2 to 5 years, subject to positive clinical outcomes in large trials that are currently underway.
More about the panel
Dr Stanislav Grof (USA)
Stan Grof has 60 years of experience as a pioneer in human consciousness research. In the past, he was Principal Investigator in a psychedelic research program at the Psychiatric Research Institute in Prague, Chief of Psychiatric Research at the Maryland Psychiatric Research Center, Assistant Professor of Psychiatry at the Johns Hopkins University, and Scholar-in-Residence at the Esalen Institute.
Grof’s publications include over 150 articles in professional journals and 25 books. Recently , he was Professor of Psychology at the California Institute of Integral Studies, conducts professional training programs in Holotropic Breathwork and transpersonal psychology, and lectures worldwide. Additionally, Stan is one of the founders and chief theoreticians of transpersonal psychology and the founding president of the International Transpersonal Association.
In 2007, he was granted the prestigious Vision 97 award from the Václav and Dagmar Havel Foundation and the Thomas R. Verny Award from the Association for Pre and Perinatal Psychology and Health in 2010.
Brigitte Grof (USA)
Brigitte Grof is a psychologist, psychotherapist and artist. In her early years she had a psychedelic experience that impacted her deeply. When her psychology studies did not answer her questions, she began studying art. In 1985 she found Stanislav Grof’s books and decided to meet him, later traveling to The Esalen Institute in Big Sur, California to participate in a month-long Holotropic Breathwork seminar with Stan and Christina Grof on “Ancient wisdom and modern science“.
She assisted in many breathwork workshops and eventually participated in a 3 year training in Switzerland. Since 1989 she has been leading her own breathwork workshops in Germany. In the early years she also worked in France and was leading the first Holotropic Breathwork workshop in Czechoslovakia with Stan’s mother Maria Grof.
From the beginning of the Grof Transpersonal Training she was offering optional modules in Germany with Sylvester Walch and a 3 year training with Ingo Jahrsetz. She has a private practice as a psychotherapist in Wiesbaden, Germany, working with Gestalt-, bodywork and breathwork. In May 2020 Stan and Brigitte Grof launched their new training in working with holotropic states of consciousness the Grof® Legacy Training. www.grof-legacy-training.com
Susan Hess Logeais (USA)
Susan Hess Logeais brings her passion as a social activist to her work as a filmmaker, creating thought provoking and inspiring films. Her background as a dancer, actress and perpetual student allows her to craft stories that do more than entertain. She also blends the knowledge and understanding earned from over 30 years of spiritual exploration with her technical experience as a filmmaker, providing her with a unique perspective on building projects that draw the viewer into a heartfelt experience of the story. Susan holds a BA in Interdisciplinary Studies with a concentration in Transformational Entertainment and Human Consciousness, and is working on her Masters in Philosophy, Cosmology and Consciousness.
Support psychedelic research and therapy development
By donating to Mind Medicine Australia, you will be helping us to accelerate the availability and best practice of psychedelic-assisted psychotherapy in Australia. We are a small organisation doing big things – we need your support.
Please click here to make a tax-deductible donation.
Mind Medicine Australia does not encourage or facilitate illegal use of psychedelics or plant medicines. MMA focus is focused on clinical and legal use only supported by the emerging science and legislative processes. Mind Medicine Australia reserves the right to record and publish webinars on various social media platforms. You agree that you will not discuss any names, locations or specific details of illegal use of psychedelics both verbally or via any written forms of communication via Mind Medicine Australia social media platforms (for example facebook, instagram and zoom private and public chat forms during the webinar). Breaches of these guidelines may result in not being able to participate in the event. We thank you for support and cooperation on these matters.
Mind Medicine Australia is focused specifically on the clinical application of medicinal psilocybin and medicinal MDMA for certain mental illnesses. We do not advocate for non-clinical use of psychedelics, MDMA, or any other prohibited substances, nor do we advocate for any changes to the law with respect to non-clinical use. Our focus is wholly clinical.